Guesting on the Joint Dynamics podcast, Phil New
Author: Michael
Company to commence clinical trials of MKK4 inhi
Predictive models offer insight into cognitive d
Vitalia CEO Niklas Anzinger on the longevity cit
Lomecel-B becomes first cell therapy to receive
Company’s ‘Immune Refresh’ approach expand
Oxford University analysis finds semaglutide doe
RF Longevity Founder Gary Arendash talks immunit
Company aims to extend female fertility window w
New insights into transcription factors and chro